TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Ribosome profiling of suspension-adapted HEK293 cells producing adeno-associated viruses

Research and experimental development services
Research laboratory services
London (UKI)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: CELL THERAPY CATAPULT LIMITED: "Ribosome profiling of suspension-adapted HEK293 cells producing adeno-associated viruses". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityCELL THERAPY CATAPULT LIMITEDScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: CELL THERAPY CATAPULT LIMITED
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for CELL THERAPY CATAPULT LIMITED. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2.8Bids / Report
0% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityCELL THERAPY CATAPULT LIMITED
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published13 Sept 2022, 10:14 BST
Last source update13 Sept 2022, 10:14 BST
Recurring procurementNot published
ClassificationResearch and experimental development services, Research laboratory services
Delivery area
London (UKI)
OCIDocds-h6vhtk-034db7
What is being bought
Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls. A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1". The samples will then be processed by the awarded Bidder. In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 35 samples will be obtained for either "Run 2" and "Run 3".
What changed
From the official release history
  1. tender value changed
    13 Sept 2022, 10:14 BST
  2. Status changed to complete
    13 Sept 2022, 10:14 BST
  3. Official notice release published
    13 Sept 2022, 10:14 BST
  4. Submission deadline changed to published date
    13 Sept 2022, 10:14 BST
  5. Buyer information updated
    13 Sept 2022, 10:14 BST
  6. Published value updated to £180,000
    4 Jul 2022, 15:38 BST
  7. Status changed to active
    4 Jul 2022, 15:38 BST
  8. Official notice release published
    4 Jul 2022, 15:38 BST
  9. Submission deadline changed to 5 Aug 2022, 12:00 BST
    4 Jul 2022, 15:38 BST
  10. Buyer information updated
    4 Jul 2022, 15:38 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector.Human cells will be subjected to AAV production in parallel with controls. A range of samples (between 21 and 35) will be generated in this experiment, designated as "Run 1". The samples will then be processed by the awarded Bidder. In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 35 samples will be obtained for either "Run 2" and "Run 3".
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    13 Sept 2022, 10:14 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 13 Sept 2022, 00:00 BST · £252,000
Commercial outcome and competition
Awards
EIRNA Bio Ltd.
Not published · Not published · active
Contracts
Contract
£252,000 · signed 13 Sept 2022, 00:00 BST · active
Bid statistics
bids: 2 (lot 1)
Buyer and organisations in this procedure

CELL THERAPY CATAPULT LIMITED

Contracting authority GB-COH-10016023
View buyer profile

  • CELL AND GENE THERAPY CATAPULT
    buyer

    GB-COH: 10016023
    12TH FLOOR TOWER WING,GUY'S HOSPITAL, GREAT MAZE POND, LONDON, UKI44, SE19RT
    procurement@ct.catapult.org.uk

  • Cell and Gene Therapy Catapult
    reviewBody

    London

  • EIRNA Bio Ltd.
    supplier

    GB-COH: 604732
    Cork, Ireland, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published